Stay updated on Clinical Trial Assessing IBI310 Similarity to Ipilimumab
Sign up to get notified when there's something new on the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page.

Latest updates to the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedAdded a new revision entry, 'Revision: v3.3.3', to the Study Record Versions. The 'HHS Vulnerability Disclosure' item and the previous revision, 'Revision: v3.3.2', were removed.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe study record history now shows a new revision entry v3.3.2, and the prior v3.2.0 entry has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedDeleted a general notice about a lapse in government funding and NIH operating status from the page. This removal does not affect the study data, status, or eligibility information.SummaryDifference0.8%

- Check59 days agoChange DetectedNew history entry dated 2025-04-10 was added, showing updated recruitment status and study status for NCT04868760. This reflects changes in the trial's current state.SummaryDifference0.1%

- Check88 days agoChange DetectedUpdated operating-status notice and version to v3.2.0; removed v3.1.0.SummaryDifference13%

- Check95 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial Assessing IBI310 Similarity to Ipilimumab
Enter your email address, and we'll notify you when there's something new on the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page.